Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
Condition: Hematopoietic Stem Cell Transplant Intervention: Other: Cardio-oncology program Sponsors: University of Michigan Rogel Cancer Center; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Cardiology | Heart | Heart Transplant | Lung Transplant | Research | Stem Cell Therapy | Stem Cells | Transplant Surgery | Transplants